ARCH Venture Partners Portfolio 2026

ARCH Venture Partners accounts for 90 tracked companies with verified cap-table data, 90 of which disclose round sizes totalling $22B. The median disclosed raise is $150M, and the largest is Resilience at $3.4B, ahead of Altos Labs ($3B) and Beam Therapeutics ($1B).

The names that recur most often on these portfolio cap tables are ARCH Venture Partners (90 companies), Alexandria Venture Investments (15 companies), GV (11 companies), F-Prime Capital (10 companies), Polaris Partners (9 companies), Altitude Life Science Ventures (6 companies). By latest disclosed round, the market skews Series A (38), Series B (24), Series C (14), Series D (4).

• Companies tracked: 90
• Disclosed funding total: $22B across 90 companies
• Median disclosed raise: $150M
• Largest raise: Resilience — $3.4B
• Stage mix: Series A 38 · Series B 24 · Series C 14 · Series D 4
• Most recent dated round: 2026-06-01

Best funded ARCH Venture Partners companies

1. Resilience — $3.4B (latest: Debt Financing)
2. Altos Labs — $3B
3. Beam Therapeutics — $1B (latest: IPO)
4. EQRx — $750M (latest: Series B)
5. Sana Biotechnology — $700M (latest: IPO)
6. Mirador Therapeutics — $650M (latest: Series B)
7. Neumora Therapeutics — $500M (latest: Series A)
8. Homology Medicines — $456M (latest: Growth)
9. Vividion Therapeutics — $362M (latest: Series B)
10. Aspen Neuroscience — $340M (latest: Series C)
11. Axon Neurosciences — $340M (latest: Series C)
12. Ollin Biosciences — $330M (latest: Series B)
13. Seaport Therapeutics — $330M (latest: Series A)
14. FogPharma — $323M (latest: Series D)
15. Sironax — $301M (latest: Series B)

Arch Venture Partners — related firms and companies (56)

• Treeline Biosciences
• Xaira Therapeutics
• Ollin Finance
• Prometheus Biosciences
• Orbital Therapeutics
• City Therapeutics
• SonoThera
• Tome Biosciences
• Investors like Franklin Templeton
• Investors like Slow Ventures
• Arch Venture Partners co-investors 2026
• Investors like Western Technology Investment
• Investors like Spark Capital
• Investors like Expansion Venture Capital
• Mindstrong
• Investors like Matrix
• Investors like Thirdbase Capital
• Investors like Storm Ventures
• Investors like Founder Collective
• Skylark Bio
• Investors like Motivate Venture Capital
• Investors like Flybridge
• Investors like Founders Fund
• Investors like Alexandria Venture Investments
• Investors like DCVC
• Investors like Kleiner Perkins
• Investors like N47
• Investors like Maveron
• AnchorDx
• Investors like HSG
• Investors like Lux Capital
• Investors like Google Ventures
• Investors like Ridge Ventures
• Founders backed by Arch Venture Partners
• Investors like Menlo Ventures
• Investors like Ventioneers
• Investors like ACME Capital
• AmberWave
• Investors like Coinbase
• Investors like Great Oaks Venture Capital
• Investors like Upfront Ventures
• Investors like Vine Ventures
• Companies backed by Arch Venture Partners
• Investors like Wellington Management
• Investors like Blockchain Capital
• Investors like Peak XV Partners
• ImmuneID
• Investors like General Catalyst
• Investors like Soma Capital
• Investors like IVP
• Investors like SV Angel
• Investors like Arch Venture Partners
• Firms like GV
• Investors like Redpoint
• Investors like Irving Investors
• SciNeuro

Arch Venture Partners alternatives · All research reports